Carroll Pamela 4
4 · GENOCEA BIOSCIENCES, INC. · Filed Feb 11, 2019
Insider Transaction Report
Form 4
Carroll Pamela
SVP IMMUNO-ONCOLOGY
Transactions
- Award
Stock Option (Right to Buy)
2019-02-07+200,000→ 200,000 totalExercise: $0.54Exp: 2029-02-07→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]The Stock Option will vest as to 1/4th of the shares subject to the option on the first anniversary of the Grant Date and thereafter as to 1/36th of the shares on each subsequent monthly anniversary of February 7, 2020 (rounded down to the nearest whole share, except for the final vesting period, with respect to which all remaining shares will vest).